Accuray Incorporated (ARAY)

NASDAQ: ARAY · IEX Real-Time Price · USD
2.08
+0.02 (0.97%)
At close: Sep 30, 2022 4:00 PM
2.07
-0.01 (-0.48%)
After-hours: Sep 30, 2022 5:30 PM EDT
0.97%
Market Cap 194.48M
Revenue (ttm) 429.91M
Net Income (ttm) -5.35M
Shares Out 93.50M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 214,190
Open 2.05
Previous Close 2.06
Day's Range 2.05 - 2.21
52-Week Range 1.70 - 5.93
Beta 1.75
Analysts Buy
Price Target 8.50 (+308.7%)
Earnings Date Nov 1, 2022

About ARAY

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company al... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Feb 8, 2007
CEO Joshua Levine
Employees 1,044
Stock Exchange NASDAQ
Ticker Symbol ARAY
Full Company Profile

Financial Performance

In 2022, Accuray's revenue was $429.91 million, an increase of 8.48% compared to the previous year's $396.29 million. Losses were -$5.35 million, -15.27% less than in 2021.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for ARAY stock is "Buy." The 12-month stock price forecast is 8.5, which is an increase of 308.65% from the latest price.

Price Target
$8.5
(308.65% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Ra...

World's Only Robotic Radiation Therapy Device Delivers Extremely Precise Treatments in Just 1 to 5 Out-Patient Sessions SUNNYVALE, Calif. , Sept. 30, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: A...

1 day ago - PRNewsWire

3 Reasons to Hold Accuray (ARAY) Stock in Your Portfolio

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

3 days ago - Zacks Investment Research

Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region

SUNNYVALE, Calif. , Sept. 14, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Seth Blacksburg, M.D.

2 weeks ago - PRNewsWire

Accuray's (ARAY) Latest Collaboration to Improve Patient Care

Accuray (ARAY) partners with Genolier Innovation Hub to unite companies from the MedTech, pharma and biosciences sectors with physicians and scientists for better patient outcomes.

3 weeks ago - Zacks Investment Research

Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster

Accuray Will Anchor Hub That Will Unite Companies From the MedTech, Pharma and Biosciences Sectors, Physicians and Scientists SUNNYVALE, Calif. , Sept. 7, 2022 /PRNewswire/ -- Accuray Incorporated (NASD...

3 weeks ago - PRNewsWire

Accuray (ARAY) Q4 Earnings Beat Estimates, Margins Down

Despite solid Product revenues, Accuray (ARAY) reports an overall soft Q4 performance.

1 month ago - Zacks Investment Research

Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates

Accuray (ARAY) delivered earnings and revenue surprises of 33.33% and 4.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results

8.5% FY22 revenue growth; Company issues guidance for FY23 SUNNYVALE, Calif. , Aug. 10, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter a...

1 month ago - PRNewsWire

Accuray to Report Fiscal Year-End 2022 Financial Results on August 10, 2022

SUNNYVALE, Calif. , July 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2022, ended June 30, 2022, after the market clo...

2 months ago - PRNewsWire

3 Reasons to Add Accuray (ARAY) Stock to Your Portfolio Now

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

2 months ago - Zacks Investment Research

Accuray CyberKnife® System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications

SUNNYVALE, Calif. , July 12, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new clinical studies presented at the 15th Congress of the International Stereotactic Radiosurg...

2 months ago - PRNewsWire

Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller

SUNNYVALE, Calif. , June 15, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Franco N.

3 months ago - PRNewsWire

Here's Why You Should Hold on to Accuray (ARAY) Stock For Now

Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.

3 months ago - Zacks Investment Research

Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules

SUNNYVALE, Calif. , June 6, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sandeep Chalke, the company's new se...

3 months ago - PRNewsWire

Accuray's (ARAY) New Tie-Up to Augment Treatment Planning

Accuray (ARAY) partners with Limbus AI to enhance the treatment planning process and patient care.

3 months ago - Zacks Investment Research

Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Ra...

Partnership will Enable Accuray to Use Limbus' Technology to Streamline the Treatment Planning Process and Increase Operational Efficiency SUNNYVALE, Calif. and SASKATCHEWAN, Canada , June 2, 2022 /PRNe...

3 months ago - PRNewsWire

Accuray Appoints Sandeep Chalke as SVP, Chief Commercial Officer

SUNNYVALE, Calif. , May 17, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Sandeep Chalke has joined the company as senior vice president, chief commercial officer effecti...

4 months ago - PRNewsWire

New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range ...

More Than 70 Abstracts Build on the Clinical Evidence Supporting the Use of These Technologies SUNNYVALE, Calif. , May 10, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that c...

4 months ago - PRNewsWire

Down 20% in 4 Weeks, Here's Why Accuray (ARAY) Looks Ripe for a Turnaround

Accuray (ARAY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates cou...

4 months ago - Zacks Investment Research

Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough ...

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies SUNNYVALE, Calif. , May 5, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that i...

4 months ago - PRNewsWire

Accuray (ARAY) Q3 Earnings Beat Estimates, Revenues Lag

Despite strong product demand, Accuray (ARAY) reports an overall soft Q3 performance.

5 months ago - Zacks Investment Research

Accuray (ARAY) Reports Q3 Loss, Misses Revenue Estimates

Accuray (ARAY) delivered earnings and revenue surprises of 83.33% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Accuray Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Boar...

Accuray Also Announces Chief Financial Officer, Ali Pervaiz SUNNYVALE, Calif. , April 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter, President, will su...

5 months ago - PRNewsWire

Accuray Reports Fiscal 2022 Third Quarter Financial Results

SUNNYVALE, Calif. , April 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2022 ended March 31, 2022.

5 months ago - PRNewsWire

Owner of Arkansas Derby Winner Named Horse After the Life-Changing Accuray CyberKnife® Radiation Therapy Technology U...

SUNNYVALE, Calif. , April 21, 2022 /PRNewswire/ -- When Al Gold, the owner of the Arkansas Derby winner Cyberknife, received a diagnosis of prostate cancer, he was determined to find a potential cure fo...

5 months ago - PRNewsWire